Global Swine Health 麻豆原创 Research Report 2024

Publication ID:

PB505248368

Publication Date:

June 4, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Swine Health market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Swine Health is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Swine Health is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Swine Health in Farm is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Swine Health include Elanco (Eli Lilly), Zoestis, Merck Animal Health, Boehringer ingelheim, Ceva Sante Animale, Vetoquinol and Virbac, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Swine Health, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Swine Health.
Report Scope
The Swine Health market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Swine Health market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Swine Health companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Elanco (Eli Lilly)
Zoestis
Merck Animal Health
Boehringer ingelheim
Ceva Sante Animale
Vetoquinol
Virbac
Segment by Type
Vaccines
Parasiticides
Anti-Infectives
Medicinal Feed Additives
Others
Segment by Application
Farm
House
Veterinary Hospitals and Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Swine Health companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Swine Health 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Vaccines
1.2.3 Parasiticides
1.2.4 Anti-Infectives
1.2.5 Medicinal Feed Additives
1.2.6 Others
1.3 麻豆原创 by Application
1.3.1 Global Swine Health 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Farm
1.3.3 House
1.3.4 Veterinary Hospitals and Clinics
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Swine Health 麻豆原创 Perspective (2019-2030)
2.2 Swine Health Growth Trends by Region
2.2.1 Global Swine Health 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Swine Health Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Swine Health Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Swine Health 麻豆原创 Dynamics
2.3.1 Swine Health Industry Trends
2.3.2 Swine Health 麻豆原创 Drivers
2.3.3 Swine Health 麻豆原创 Challenges
2.3.4 Swine Health 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Swine Health Players by Revenue
3.1.1 Global Top Swine Health Players by Revenue (2019-2024)
3.1.2 Global Swine Health Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Swine Health 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Swine Health Revenue
3.4 Global Swine Health 麻豆原创 Concentration Ratio
3.4.1 Global Swine Health 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Swine Health Revenue in 2023
3.5 Swine Health Key Players Head office and Area Served
3.6 Key Players Swine Health Product Solution and Service
3.7 Date of Enter into Swine Health 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Swine Health Breakdown Data by Type
4.1 Global Swine Health Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Swine Health Forecasted 麻豆原创 Size by Type (2025-2030)
5 Swine Health Breakdown Data by Application
5.1 Global Swine Health Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Swine Health Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Swine Health 麻豆原创 Size (2019-2030)
6.2 North America Swine Health 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Swine Health 麻豆原创 Size by Country (2019-2024)
6.4 North America Swine Health 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Swine Health 麻豆原创 Size (2019-2030)
7.2 Europe Swine Health 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Swine Health 麻豆原创 Size by Country (2019-2024)
7.4 Europe Swine Health 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Swine Health 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Swine Health 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Swine Health 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Swine Health 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Swine Health 麻豆原创 Size (2019-2030)
9.2 Latin America Swine Health 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Swine Health 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Swine Health 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Swine Health 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Swine Health 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Swine Health 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Swine Health 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Elanco (Eli Lilly)
11.1.1 Elanco (Eli Lilly) Company Detail
11.1.2 Elanco (Eli Lilly) Business Overview
11.1.3 Elanco (Eli Lilly) Swine Health Introduction
11.1.4 Elanco (Eli Lilly) Revenue in Swine Health Business (2019-2024)
11.1.5 Elanco (Eli Lilly) Recent Development
11.2 Zoestis
11.2.1 Zoestis Company Detail
11.2.2 Zoestis Business Overview
11.2.3 Zoestis Swine Health Introduction
11.2.4 Zoestis Revenue in Swine Health Business (2019-2024)
11.2.5 Zoestis Recent Development
11.3 Merck Animal Health
11.3.1 Merck Animal Health Company Detail
11.3.2 Merck Animal Health Business Overview
11.3.3 Merck Animal Health Swine Health Introduction
11.3.4 Merck Animal Health Revenue in Swine Health Business (2019-2024)
11.3.5 Merck Animal Health Recent Development
11.4 Boehringer ingelheim
11.4.1 Boehringer ingelheim Company Detail
11.4.2 Boehringer ingelheim Business Overview
11.4.3 Boehringer ingelheim Swine Health Introduction
11.4.4 Boehringer ingelheim Revenue in Swine Health Business (2019-2024)
11.4.5 Boehringer ingelheim Recent Development
11.5 Ceva Sante Animale
11.5.1 Ceva Sante Animale Company Detail
11.5.2 Ceva Sante Animale Business Overview
11.5.3 Ceva Sante Animale Swine Health Introduction
11.5.4 Ceva Sante Animale Revenue in Swine Health Business (2019-2024)
11.5.5 Ceva Sante Animale Recent Development
11.6 Vetoquinol
11.6.1 Vetoquinol Company Detail
11.6.2 Vetoquinol Business Overview
11.6.3 Vetoquinol Swine Health Introduction
11.6.4 Vetoquinol Revenue in Swine Health Business (2019-2024)
11.6.5 Vetoquinol Recent Development
11.7 Virbac
11.7.1 Virbac Company Detail
11.7.2 Virbac Business Overview
11.7.3 Virbac Swine Health Introduction
11.7.4 Virbac Revenue in Swine Health Business (2019-2024)
11.7.5 Virbac Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Elanco (Eli Lilly)
Zoestis
Merck Animal Health
Boehringer ingelheim
Ceva Sante Animale
Vetoquinol
Virbac

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.